Drug Testing Locations - New Orleans, LA

Drug Testing in New Orleans, LA

New Orleans, Louisiana Statistics

New Orleans, located in Orleans Parish, faces a high rate of opioid-related deaths, with approximately 37.2 deaths per 100,000 people in recent years.

Orleans Parish witnessed a 21% increase in emergency room visits related to drug overdoses over the past four years.

Methamphetamine use in New Orleans has risen, with a 15% increase in arrests related to the drug since 2018.

In 2022, 52% of the drug-related arrests in New Orleans involved marijuana possession.

Orleans Parish's drug court program has seen a 30% increase in participants seeking rehabilitation rather than incarceration.

Heroin remains a significant issue in New Orleans, with confiscation amounts more than doubling from 2019 to 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in New Orleans, LA & Drug Testing Policies

Many employers in New Orleans have strict drug testing policies designed to maintain a safe and productive workplace. Companies in industries such as construction and transportation often require pre-employment and random drug screenings.

The state's Department of Labor provides guidelines and support for employers looking to implement or enhance their drug testing policies, ensuring compliance with local and federal regulations. For more information, visit the Louisiana Workforce Commission.

Government Efforts with Drug Problems in New Orleans, LA

In New Orleans, government efforts to tackle drug issues include partnerships with Orleans Parish health services, focusing on rehabilitation over incarceration. Local initiatives aim to increase access to treatment and recovery services, helping residents struggling with addiction find the necessary support.

The state of Louisiana has allocated resources for public awareness campaigns targeting drug abuse. Agencies such as the Louisiana Department of Health provide information and resources for addressing substance abuse. Learn more.

Local Drug Busts & News in New Orleans, LA

In a recent drug bust in New Orleans, local law enforcement collaborated with federal agencies to dismantle a large drug trafficking ring. The operation, which took months of planning, led to multiple arrests and the seizure of significant quantities of narcotics, including heroin and methamphetamine. Authorities emphasized the importance of community cooperation in providing tips that proved crucial to the success of the sting.

New Orleans has long grappled with drug-related issues, and recent events have put a spotlight on the ongoing battle against narcotics. Community leaders have been vocal about the need for better resources and support systems to help those affected by addiction. Efforts are underway to increase access to treatment programs and to promote educational initiatives aimed at preventing drug abuse among the city's youth.

A significant development in New Orleans' drug-related efforts was the implementation of a task force dedicated to tackling the opioid crisis. This initiative, involving doctors, counselors, and law enforcement, aims to provide a multi-pronged approach to reducing opioid dependency. Part of their strategy focuses on educating medical professionals about responsible prescription practices as well as offering support to overdose survivors and their families.

Local events in New Orleans, such as drug take-back days, have provided a safe way for residents to dispose of unused medications. These community-driven initiatives seek to minimize the potential for misuse within households. Participation in such events has been growing steadily, reflecting a rising community awareness and involvement in efforts to address drug-related challenges in the region.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in New Orleans, LA. Trusted by employers nationwide for accurate results and exceptional service.

Louisiana DOT/Non DOT Physicals

Louisiana Vision Tests

Louisiana Audiograms

Louisiana Respirator Fit Tests

Louisiana Lift Tests

Louisiana Background Checks

Clinical Testing Services

TB Testing in LA

Diabetes Testing in LA

Infectious Disease Testing in LA

Sickle Cell Anemia Testing in LA

Women/Men's Health Testing in LA

Resources & Citations

Odyssey House

Bridge House

NOLA Ready

CrescentCare

DrugAbuse.com

Louisiana Public Health Institute

Recovery.org

Louisiana Department of Health

Drug Testing Near New Orleans, LA

River Ridge, LA

Harahan, LA

Estelle, LA

Chalmette, LA

Elmwood, LA

Woodmere, LA

Bridge City, LA

Timberlane, LA

Westwego, LA

Metairie, LA

Arabi, LA

Harvey, LA

Marrero, LA

Gretna, LA

Frequently Asked Questions

Customer Reviews